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SUMMARY
Testicular development and function is the culmination of a complex process of autocrine, paracrine and endocrine interactions
between multiple cell types. Dissecting this has classically involved the use of systemic treatments to perturb endocrine function, or
more recently, transgenic models to knockout individual genes. However, targeting genes one at a time does not capture the more
wide-ranging role of each cell type in its entirety. An often overlooked, but extremely powerful approach to elucidate cellular function
is the use of cell ablation strategies, specifically removing one cellular population and examining the resultant impacts on develop-
ment and function. Cell ablation studies reveal a more holistic overview of cell–cell interactions. This not only identifies important
roles for the ablated cell type, which warrant further downstream study, but also, and importantly, reveals functions within the tissue
that occur completely independently of the ablated cell type. To date, cell ablation studies in the testis have specifically removed
germ cells, Leydig cells, macrophages and recently Sertoli cells. These studies have provided great leaps in understanding not possi-
ble via other approaches; as such, cell ablation represents an essential component in the researchers’ tool-kit, and should be viewed
as a complement to the more mainstream approaches to advancing our understanding of testis biology. In this review, we summarise
the cell ablation models used in the testis, and discuss what each of these have taught us about testis development and function.
INTRODUCTION
Testicular development and function is the culmination of a
complex process of autocrine, paracrine and endocrine interac-
tions between multiple cell types. Early studies that focussed
upon dissecting these interactions generally relied on cell cul-
ture systems or systemic interventions in vivo using chemicals
or surgical hypophysectomy to suppress endocrine and down-
stream testicular function. While these studies have given valu-
able insight into testis biology they suffer the serious drawbacks
that cells do not behave normally in culture, whereas systemic
interventions cannot assign impacts or roles to specific cell types
or genes. A more detailed understanding of testis development
and function has arisen from the use of transgenic mouse mod-
els, ablating the function of single genes to determine their indi-
vidual roles. The development of conditional gene targeting has
further refined this, permitting ablation of specific gene function
in single cell types, and indeed the combination of these
reductionist approaches has identified many of the key genes
essential for testis development and function. However, target-
ing genes one at a time does not capture the more wide-ranging
role of each cell type in its entirety. An often overlooked, but
extremely powerful approach to elucidate cellular function is the
use of cell ablation strategies, specifically removing one cellular
population and examining the impacts to reveal the importance
of that cell type for development and function.
The major criticism levelled at cell ablation studies is the
crudeness of the approach. It has been argued that removing an
entire cell population, and thereby disrupting hundreds of sig-
nalling pathways simultaneously, provides little information
regarding how the cell type in question influences other cellular
populations. Whilst this is indeed true, and focussing on specific
signalling pathways using this approach is flawed, evidence has
demonstrated time and again that the power of cell ablation
studies is to reveal a more holistic overview of cell–cell
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interactions. This not only identifies important roles for the
ablated cell type, which warrant further downstream study, but
also, and importantly, reveals functions within the tissue that
occur completely independently of the ablated cell type. To date,
cell ablation studies in the testis have specifically removed germ
cells, Leydig cells, macrophages and recently Sertoli cells
(Fig. 1). In this review, we will summarize the cell ablation mod-
els used in the testis, and discuss what each of these have taught
us about testis development and function.
APPROACHES TO CELL ABLATION
A range of options are available to those wishing to selectively
ablate a single population of cells from an organ, but there are
several key features shared by all approaches. The choice of
method to be used should: (i) be specific, only affect the target
cell type; (ii) be precisely controllable, for example so that timing
of cell death, etc., is known, (iii) have high efficiency of ablation,
completely or almost completely remove the target population,
(iv) act quickly, such that impacts can be directly attributed to
cell loss; and (v) have minimal off-target toxicity, such that other
cell populations or organs are not affected. An overview of avail-
able options and their associated efficacy is shown in Fig. 2, and
their impacts on testis architecture in Fig. 3.
Many models lacking a specific cell type have been generated
as a serendipitous consequence of mutation or gene knockout.
At the most basic level, knockout of Sry or Sox9 leads to sex
reversal through failure of Sertoli cell specification, fundamen-
tally demonstrating the requirement of Sertoli cells for mas-
culinization [reviewed in (Kobayashi et al., 2005; Wilhelm et al.,
2013)]. Within the developing testis knockout of other genes
can lead to absence of specific cell types, for example knockout
of PDGFR-alpha (Brennan et al., 2003) impacts on foetal Leydig
cell development, whereas knockout of desert hedgehog (DHH)
(Clark et al., 2000), or COUPTFII (Qin et al., 2008) leads to
absence of the adult Leydig cell population; Wv mutations of
cKit lead to near germ-free testes, through failure of primordial
germ cell migration (De Franca et al., 1994), whereas mutations
such as the cell-specific loss of AR from Sertoli cells leads to loss
of post-meiotic germ cells (Chang et al., 2004; De Gendt et al.,
2004). In each of these cases, however, it is challenging to assign
any downstream phenotypic impact specifically to loss of gene
function or to the wider effects of cell ablation. As such, and
with the exception of the W/Wv mouse, few of these gene
knockout models have been used widely as a model of cell abla-
tion outside the context of their own gene function. To widen
the scope of cell ablation to different genotypes and species
several alternative approaches have been developed that induce
cell loss of a specific testicular cell population without the
requirement for gene knockout.
GERM CELLS
By far the most common approach to ablation of germ cells
from the testis utilizes nascent chemotherapy agents such as
busulfan (Myleran). The impact of busulfan on the spermato-
genic cell population was first identified in the 1960s (Jackson
et al., 1962), and its ability to apparently selectively remove the
male germ cell population has been exploited widely in the past
50 years. This has been both in the pursuit of understanding
about the role of germ cells in the testis, and also as a technical
tool, important in preparation of recipients prior to germ cell
transplantation (Brinster & Zimmermann, 1994; Brinster et al.,
2003) [for review see (Brinster, 2002)], for fertility preservation
and as a tool to investigate the spermatogonial stem cell niche.
Busulfan is an alkylating agent that targets rapidly dividing mito-
tic spermatogonia resulting in apoptosis of this germ cell stage
within 1 week, with a second wave of apoptosis in meiotic sper-
matocytes after 2 weeks (Choi et al., 2004) (Fig. 2). For these rea-
sons, busulfan requires several weeks to completely ablate germ
cells from the testis as the residual post-mitotic stages complete
spermatogenesis and are released into the seminiferous tubule
lumen (Medrano et al., 2014) (Fig. 3).
Exposure to radiation will also cause mitotic cells to undergo
apoptosis and has been used as a technique to study the effects
of germ cell ablation (Fig. 2). At high doses radiation exposure in
Figure 1 Schematic representation of the testis
showing ablated cell populations. To date
methodologies have been employed to selec-
tively ablate germ cells, Leydig cells, Macro-
phages and recently Sertoli cells. By removing a
single population and asking ‘what changes’
and ‘what remains the same?’, these studies
have proven instrumental in defining our funda-
mental understanding of cell–cell communica-
tion in the testis, assigning specific roles to
individual cell types whilst ruling out others.
SC = Sertoli cell; PM = Peritubular Myoid cell;
LC = Leydig cell; Stem cell = Leydig stem cell.
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rat models can lead to infertility associated with a persistent fail-
ure to re-establish spermatogenesis (Kangasniemi et al., 1996)
and this has provided insight into how radiation-induced infer-
tility can occur, with direct relevance to cancer patients under-
going radiotherapy. For example reciprocal germ cell transplant
studies (irradiated spermatogonia into non-irradiated hosts or
vice versa) reveal that, whereas germ cell loss is likely a direct
result of impacts on germ cells, failure to re-establish spermato-
genesis is a somatic cell problem rather than any direct impact
on spermatogonial stem cells (Zhang et al., 2007), suggesting
radiation acts on both germ cells and somatic cells
simultaneously.
The ability of very defined doses of radiation to selectively
remove the germ cell population has also been explored as a
method to generate recipient animals for germ cell transplants,
especially in scenarios where genetic mutants lacking germ cells
(e.g. W/Wv) mice are unavailable or inappropriate (e.g. difficult
to breed, immunocompatibility issues with donor cells, use of
other species) (Zhang et al., 2006). Even within mice, the
removal of germ cells using busulfan is a strain-dependent bal-
ance between the required toxicity to kill sufficient germ cells
and the sensitivity of the animal to the wider toxicological effects
of the drug, particularly on haematopoiesis (Meistrich et al.,
1978; Abuelhija et al., 2013). In this context, radiation provides a
useful alternative to busulfan; the fact that it has not been taken
up widely probably reflects the general move of researchers
away from use of radiation wherever possible and the ready
availability and convenience of a single busulfan injection which
requires significantly less specific training, infrastructure or
administrative oversight.
Figure 2 Schematic overview of depletion and
recovery timings for each model of cell ablation.
A schematic diagram comparing the rapidity of
cell depletion and the duration of recovery days
(d) after treatment, for each testicular cell type
and method: (A) Leydig cells and macrophages
when ablated independently or simultaneously;
(B) Germ cells and (C) Sertoli cells. ST: seminifer-
ous tubules, EDS: Ethylene dimethane
sulphonate, CL2MDP: Liposome-entrapped
dichloromethylene diphosphonate, BUS: busul-
fan, DTA: active diphtheria fragment A, DTR:
diphtheria receptor, DTX: diphtheria toxin.
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An alternative model to either busulfan or radiation utilises a
unique transgenic approach, expressing the Herpes Simplex
virus Thymidine Kinase (TK) transgene from an inhibin-alpha
promoter, which directs expression to Leydig and Sertoli cells,
but not spermatogonia (Ahtiainen et al., 2004). The TK enzyme
phosphorylates analogue nucleosides such as famciclovir, which
are then incorporated into replicating DNA, acting as chain ter-
minators and leading to eventual cell death. In the Inha/TK
mouse, mitotically quiescent Sertoli and Leydig cells are resis-
tant to the effects of TK, whereas the rapidly dividing spermato-
gonia cells are susceptible, probably through a bystander effect
mediated by the gap junctions with Sertoli cells (Ahtiainen et al.,
2004). As with busulfan, the ontogeny of cell death is gradual,
taking 4 weeks to remove all germ cell populations through
selective ablation of spermatogonia followed by natural develop-
ment and sloughing of later germ cell stages until the testis is
devoid of germ cells (Fig. 2). Whilst time to germ cell clearance
is long, the authors show that a 3-day treatment is sufficient to
completely ablate all germ cell populations, and they observe no
recovery 3 months post treatment. This could either be attribu-
ted to complete cell death of all spermatogonial stem cells, or
impacts on Sertoli cells that prevent recovery of spermatogene-
sis. (Ahtiainen et al., 2004).
Diphtheria toxin (DTX) has also been used in several models
of germ cell ablation. In one model expression of the diphtheria
toxin A-chain gene is directed to the male germline by fusion to
1 KB of the five prime flanking DNA of the rat male-germ cell-
specific histone H1t gene (Bartell et al., 2000). The H1t promoter
fragment drives cell-specific expression of the diphtheria toxin A
fragment in pre-spermatogonia. This results in widespread cell
death, with just a few germ cells reaching the pachytene sperma-
tocyte stage, and by 13 weeks of age the testis is almost
Figure 3 Cell-specific ablation in the testis. Example of testis histology and immunolocalisation of cell-specific markers following Germ cell, Leydig cell or
Sertoli cell ablation respectively (indicated by arrowheads). (A) Germ cell ablation in mouse using busulfan (DDX4 staining to mark germ cells); (B) Germ
cell ablation in Stra8-Cre;iDTR mice using DTX injection (DDX4 staining to mark germ cells); (C) Leydig cell ablation in rat using EDS (CYP11A1 staining
to mark Leydig cells). (D) Sertoli cell ablation in Amh-Cre;iDTRmice using DTX injection (SOX9 staining to mark Sertoli cells); (scale bar: 100 lm).
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completely devoid of germ cells (Fig. 2). In contrast, females are
completely fertile (Bartell et al., 2000). Although the testes in
these animals are extremely small, seminal vesicle weights are
normal, suggesting that loss of germ cells does not impact
androgen production.
In contrast to direct expression of the DTX A-chain inside
germ cells, other transgenic approaches have been used which
exploit the natural resistance of mice to DTX. In primates, DTX
enters cells by binding to a cognate HBEGF receptor (also known
as Diphtheria Toxin Receptor – DTR) and it is this internalisation
followed by cleavage of the A-chain, which leads to cell death. In
mice, DTX has low affinity for mHBEGF but transgenic expres-
sion of an inducible primate iDTR within mouse germ cells con-
fers sensitivity to injected recombinant DTX. Breeding of iDTR
to a germ cell Cre Recombinase line (Stra8-Cre) (Sadate-
Ngatchou et al., 2008) results in expression of iDTR in male germ
cells from postnatal day (pnd) 3 onwards (Rebourcet et al.,
2014b). These animals show normal fertility but germ cell-speci-
fic cell death can be induced at any time of choosing through
injection of DTX. Cell death is rapid, with apoptosis induced
within 24 h and near complete clearance of germ cells from the
seminiferous tubules within 7 days of a single injection (Fig. 2
and 3). To date this approach combines the fastest clearance of
all germ cells with the lowest off-target toxicity although this
approach does rely on the presence of multiple transgenes,
which is impractical in most contexts. Furthermore, because of
the variable nature of the Cre used (Bao et al., 2013), a small
number (<1%) of spermatogonia fail to express the receptor and
thus remain in the testis. However, the fact that these residual
cells are able to repopulate the testis to produce complete sper-
matogenesis, demonstrates there is no long-term impact of germ
cell ablation on testis function using this approach (Rebourcet
et al., 2014a,b).
Germ cell ablation has significantly enhanced our understand-
ing of testis development and function (Fig. 4). The most striking
observation arising from germ cell loss is that the testis can form
a normal architecture in the complete absence of germ cells.
This suggests that germ cells play little role in the architecture of
the developing testis. Indeed W/Wv mice, which lack germ cells,
have been used to demonstrate that germ cells play no role in
the increase in Sertoli cell numbers observed in cases of
hypothyroidism (Saxena et al., 2002), strongly suggesting that
hypothyroidism acts through a direct effect on Sertoli cells
[reviewed in (Holsberger & Cooke, 2005)]. This apparent lack of
impact on testicular architecture is also observed if germ cells
are ablated in adulthood (Fig. 3), with no effect seen on either
Sertoli cell (De Franca et al., 1994; O’Shaughnessy et al., 2003) or
Leydig cell numbers (O’Shaughnessy et al., 2003) and retention
of general testicular architecture. Further to this, ablation of
germ cells in adulthood does not impact on Leydig cell gene
expression (O’Shaughnessy et al., 2008a) or androgen concen-
trations, with no change observed in either intratesticular testos-
terone (O’Shaughnessy et al., 2008a) or circulating testosterone
concentrations (Gomes et al., 1973; Morris et al., 1987; De
Franca et al., 1994), suggesting that germ cells play little role in
control of testicular androgen production. In contrast to the lack
of effect on Leydig cells, germ cell loss significantly impacts Ser-
toli cell anatomy (a significant reduction in smooth endoplasmic
reticulum (De Franca et al., 1994)) and function (although not
Sertoli cell number). By following the progressive nature of germ
cell loss after busulfan treatment, it is clear that the Sertoli cells
are most influenced by post-meiotic germ cells, with significant
changes in Sertoli cell gene transcript levels apparent only when
these germ cells are lost from the seminiferous epithelium, ~15–
30 days post busulfan injection. Whilst there are also gene
expression changes at earlier time points, these are not as wide-
spread suggesting spermatogonia and spermatocytes exert less
influence over Sertoli cell gene expression (O’Shaughnessy et al.,
2008b).
Perhaps one of the most intriguing observations is the rela-
tionship between germ cells and circulating follicle stimulating
hormone (FSH) levels. The current paradigm dictates that FSH
levels will increase in response to a reduction in germ cell num-
ber, via antagonism of Sertoli cell production of InhibinB, which
acts in a negative feedback loop in the pituitary [reviewed in
(Meachem et al., 2001)]. Whilst this concept is supported by the
observation of a significant increase in circulating FSH concen-
trations following busulfan-induced germ cell loss in the rat
(Gomes et al., 1973), and in the mutant W/Wv mouse (De Franca
et al., 1994), this is not observed in wild-type mice where in con-
trast, complete loss of germ cells either through busulfan injec-
tion (O’Shaughnessy et al., 2008a) or diphtheria toxin injection
(Rebourcet, O’Shaughnessy, Smith, unpublished data) results in
no increase in FSH levels whatsoever. It is difficult to reconcile
these observations, although the fact that FSH levels are signifi-
cantly increased in a mouse model of Sertoli cell ablation (Re-
bourcet et al., 2014a) suggests that the primary insult may be to
the Sertoli cells. It could therefore be speculated that either the
rat germ cells influence Sertoli cells to a greater extent than in
the mouse, or alternatively, that rat Sertoli cells are more sensi-
tive to perturbation by busulfan.
In addition to advancing our understanding regarding the con-
trol of testis development and cell-cell interactions, germ cell
ablation, when combined with subsequent germ cell transplan-
tation has also provided significant understanding of germ cell
development. In a groundbreaking study published in 1994,
Brinster and Zimmermann showed that spermatogenesis was
possible following germ cell transplantation in immunocompat-
able mice (Brinster & Zimmermann, 1994). Key to the success of
the study was the use of mice lacking germ cells, with both W/
Wv mice and busulfan-treated mice successfully used. This revo-
lutionary approach opened up the possibility of supporting sper-
matogenesis in response to adverse clinical conditions, for
example fertility preservation in cancer patients. Along the way,
however, use of germ cell ablation and transplantation has also
enlightened our understanding of germ cell development and
function, for example permitting the characterization of the pat-
tern and kinetics of donor-derived spermatogonial stem cell
colonisation. This includes the observation that Sertoli cells
recognise and permit retrograde spermatogonial transit through
the tight junctions of the blood–testis barrier (Nagano et al.,
1999). Through this approach it has also been shown that cross-
species transplantation of rat spermatogonia into mice results in
full ‘rat’ spermatogenesis (Clouthier et al., 1996), with the germ
cells taking 52–53 days to fully mature, rather than the normal
35 days of mouse spermatogenesis (Franca et al., 1998). This
means that it is the germ cells, rather than Sertoli cells, which
control the timing and progress of spermatogenesis.
Identifying the stem cells amongst the spermatogonia lining
the basement membrane of the seminiferous tubules using
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morphological parameters has proven challenging. Germ cell
ablation and transplantation has been used to estimate the num-
ber of spermatogonial stem cells through counting of individual
colonies of expanding spermatogonia marked with B-galactosi-
dase. Initial estimates using transplant into adult mice has pro-
duced an estimate of ~0.002% of total spermatogonia number
(Nagano et al., 1999), however, transplant into younger recipi-
ents in which the blood–testis barrier (BTB) had yet to form
increases colony number 10-fold suggesting the initial estimates
were hindered by the ability for stem cells to cross the BTB in a
retrograde direction and colonise available niches (Shinohara
et al., 2001). The functional lifespan of spermatogonial stem
cells has also been established using cell ablation and transplan-
tation. These studies show that, whilst under normal circum-
stances stem cell number and proliferative capacity drops off
with age, stem cells retain their proliferative capacity if trans-
planted into younger mice. Serial transplantation experiments
demonstrate that this remains the case for more than 2 years
in vivo in the mouse, significantly longer than the normal breed-
ing window (Ogawa et al., 2003; Ryu et al., 2006), and highlight-
ing the degeneration of the niche as the limiting factor in
lifelong spermatogenesis.
Germ cell ablation and transplantation studies have also been
used to establish when germline stem cells acquire spermatogo-
nial stem cell activity. Ohta et al., (2004) have shown that gono-
cytes collected from 13.5 days post coitum (dpc) embryos or
later stages can colonise seminiferous tubules. Moreover, when
transplanted into younger, 5–10 day old recipients, not only pri-
mordial germ cells from all foetal ages, but also epiblasts from
6.5 dpc embryos could colonise and go on to produce spermato-
zoa (Chuma et al., 2005). Taking this to extreme levels, it is now
possible (but challenging and with poor efficiency) to generate
PGC-like cells from ES cells and transplant these into host testes
to produce spermatids and live mice through assisted reproduc-
tion techniques (Hayashi et al., 2011).
As discussed above, the development of knockout mouse
models has revolutionised genetics and our ability to study com-
plex biochemical and physiological mechanisms. Until the more
recent development of conditional knockout technologies, how-
ever, one of the key issues when examining the role of genes in
knockout animals was the inability to assign gene function to a
specific cell type if the gene is expressed in several cells. Germ
cell ablation and transplantation using mutant donor germ cells
or mutant recipients has been successfully used to dissect the
Figure 4 What have cell-ablation models taught us? Overall testis differentiation, somatic cell development and testicular endocrine function is indepen-
dent of Germ cell regulation. However, germ cell-ablation models have highlighted the intricate cross talk between germ cells and Sertoli cells. germ cell
ablation combined with transplantation studies have also shown that germ cells control the timing and the progression of spermatogenesis, although the
lifespan of the spermatogonial stem cells and consequently spermatogenesis depends on the somatic cell niche. Leydig cells are the source of androgens,
essential for spermatogenesis. When ablated, Leydig cells are able to regenerate from peritubular progenitors under regulation from Luteinising hormone
(LH) and other testicular secreted factors. Cell ablation studies have permitted the complete dissection of this regeneration process, which is believed to
recapitulate normal adult Leydig cell development in most respects. Leydig cell-ablation studies have also aided the identification of Leydig cell-specific tran-
scripts. The testis is an immune privileged organ. Macrophage ablation studies have shown that these cells are not essential to overall seminiferous tubules
development. They prevent local systemic inflammation engendered by Leydig cell death. Macrophages and Leydig cells share an intricate physical and
physiological relationship; macrophage ablation has revealed that this relationship is essential for Leydig cell development and regeneration. Sertoli cells
orchestrate testis differentiation. In prenatal and pre-pubertal life they are essential for the development and maintenance of testicular architecture. Sertoli
cells are crucial components of the spermatogonial stem cell niche, permitting germ cell development and differentiation (spermatogenesis). Sertoli cell-ab-
lation models have shown that, following their initial differentiation, Fetal Leydig cells are no longer dependent on Sertoli cells. In contrast the development
and survival of the adult Leydig cell population is fundamentally dependent upon Sertoli cells.
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Steel/cKit tyrosine receptor system, mutations in which lead to a
block in spermatogenesis. In the testes of mice homozygous for
mutations in either cKit (W/Wv) (germ cell) or the kit ligand Steel
factor (Sl/SLd) (Sertoli cell) the seminiferous tubules lack almost
all germ cells (Ogawa et al., 2000). However, transplantation of
wild-type germ cells into W/Wv mice restores fertility in W/Wv
mutants, whereas transplantation of spermatogonial stem cells
from Sl/Sld males into W/Wv mice also restores fertility (Ogawa
et al., 2000), both by overcoming the cell-specific impacts of
their respective gene loss. As the expression of the ligand and the
receptor differs (ligand-SC and receptor-GC), the germ cell loss
defect in both mutants originate either from the precursor cells
(W/Wv) or from the microenvironment (Sl/SLd). Therefore, the
outcome after transplantation of green fluorescent protein (GFP)
tagged germ cells into the seminiferous tubules of Sl/SLd mice
resulted in colonisation but no differentiation of the GFP germ
cells, which remain as spermatogonia. In contrast, when they
are re-transplanted into W/Wv mice complete spermatogenesis
was achieved (Ohta et al., 2000).
This initial proof of principle for assigning gene roles to either
germ cell or somatic cell populations has been expanded to
other genes, showing, for example that transplantation of sper-
matogonia from juvenile spermatogonial depletion jsd-mutant
mice, which show an arrest of spermatogenesis after one round
of meiosis, into wild-type host mice fails to restore fertility. In
contrast, transplant of wild-type germ cells into a jsd host leads
to full spermatogenesis, confirming that the jsd mutation is an
intrinsic problem with the germ cells, and not the somatic envi-
ronment (Boettger-Tong et al., 2000). In a similar approach,
transplantation of germ cells from estrogen receptor-alpha
(aERKO) knockout mice, which are infertile, into germ cell-de-
pleted hosts leads to normal spermatogenesis, showing it is the
somatic environment underpinning this particular infertility
phenotype (Mahato et al., 2000). Similarly, germ cells from infer-
tile testicular feminized (Tfm) mice (which have a null mutation
in the androgen receptor (Ar)) are able to go on to produce sper-
matozoa once transplanted into a wild-type host mouse (John-
ston et al., 2001). This approach has been widely exploited with
investigations into the role of genes such as Etv5 (Morrow et al.,
2007) Claudin11 and Rac1 (Takashima et al., 2011) and factors
such as vitamin-A (McLean et al., 2002) in the regulation of sper-
matogonial stem cell niche populations [reviewed in (Kanatsu-
Shinohara & Shinohara, 2013)].
To a large extent the development of conditional gene target-
ing and the wide availability of germ cell expressing Cre recom-
binase lines [reviewed in (Smith, 2011)] has superseded the
requirement for such transplantation experiments to establish
gene function. In fact the protocol has become so mainstream
that today it is largely exploited for what it can do as a technol-
ogy, for example xenogenic germ cell development for endan-
gered species [which is itself not without problems (reviewed in
(Paris et al., 2004)], or as an approach to generate transgenic
domesticated animals (Zeng et al., 2013). Most recently germ
cell ablation and transplantation has been associated with a
drive towards the generation of artificial gametes (gametes gen-
erated by manipulation of their progenitors or of somatic cells)
(Hendriks et al., 2015a), which raises significant moral and ethi-
cal questions that need to be debated by society in the coming
years (Hendriks et al., 2015b).
LEYDIG CELLS
The Leydig cells are the source of androgen production by the
testis and these androgens are essential for male phenotypic dif-
ferentiation, fertility and libido. It is clear that in eutherian mam-
mals there are two populations of Leydig cells which arise
sequentially during development (Roosen-Runge & Anderson,
1959; Lording & De Kretser, 1972). The foetal population of cells
develops soon after testis differentiation and is essential for foe-
tal synthesis of androgen and INSL3 which ensure masculiniza-
tion of the foetus and testis descent (Nef & Parada, 1999). In all
mammals so far studied a second, adult population of Leydig
cells starts to develop in the pre-pubertal period [around days 7–
10 in mice (Baker et al., 1999; Nef et al., 2000)]. This adult popu-
lation of cells secretes androgens essential for male phenotypic
and behavioural development and puberty and maintains fertil-
ity in the adult. The adult Leydig cells are completely dependent
on LH support for both development and adult function; in the
absence of LH few adult Leydig cells develop and circulating
testosterone levels are barely detectable (O’Shaughnessy et al.,
1998; Baker & O’Shaughnessy, 2001; Lei et al., 2001; Zhang et al.,
2001). In contrast, the foetal Leydig cells in rodents appear to
function largely independently of hormonal support (El Gehani
et al., 1998; O’Shaughnessy et al., 1998; Baker et al., 1999; Lei
et al., 2001; Zhang et al., 2006) although in other species LH (or
hCG in humans) is required for foetal androgen production
(O’Shaughnessy & Fowler, 2011).
Leydig cell ablation has proven incredibly informative in
improving our understanding of testis development and func-
tion (Fig. 4). Studies of Leydig cell ablation started largely by
chance through observations of the effects of ethane dimethane
sulphonate (EDS) in the rat. In the 1960s Harold Jackson and
colleagues were examining anti-spermatogenic agents as poten-
tial regulators of male fertility [see (Jackson, 1970)]. EDS is struc-
turally very similar to busulfan and a single dose was shown, like
busulfan, to cause disruption of the seminiferous epithelium
over a similar time scale (Jackson, 1970). One significant differ-
ence, however, was that treatment with EDS led to a marked loss
in weight of the prostate and seminal vesicles indicating loss of
testosterone and a change in Leydig cell function (Jackson, 1970;
Jackson & Jackson, 1984). Subsequently, in the mid-1980s it was
shown that EDS acts by causing rapid ablation of the Leydig cells
within 48 h of a single injection (Kerr et al., 1985; Molenaar
et al., 1985; Morris et al., 1986) (Fig. 2). Other effects of EDS on
the testis (e.g. loss of spermatogenesis) were shown to be due
largely to the consequences of androgen withdrawal although
some effects on Sertoli cell and peritubular myoid cell function
have been reported (Verhoeven et al., 1989; Roberts & Griswold,
1990). EDS is a glutathione-dependent alkylating agent (Kelce &
Zirkin, 1993; Morris, 1996), which induces apoptosis in Leydig
cells through activation of the Fas system (Taylor et al., 1999;
Kim et al., 2000) and possible upregulation of N-myc down-
stream-regulated gene 2 (NDRG2) (Li et al., 2012). It is not clear,
however, how EDS acts to induce the apoptotic pathway or why
EDS is specific to Leydig cells. There is also strong species speci-
ficity to the actions of EDS on Leydig cells with little effect of the
toxicant seen in a number of species including the mouse, dog
and monkey, whereas others such as the rat, guinea pig and frog
show high sensitivity (Morris, 1996). This may provide a further
clue to the specificity of the toxicant as it has been shown that in
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rats the Leydig cells show specific expression of a number of
metabolic enzymes which act to metabolise xenotoxicants
(O’Shaughnessy et al., 2014). It is possible that one of these
enzymes may serve to activate EDS and species specificity may
arise from variability in substrate specificity or enzyme isoforms
expressed.
In the years since its actions were first identified EDS has
proved an extremely valuable tool in our efforts to understand
Leydig cell biology. Its usefulness is only limited by its failure to
act in mice (except at very high doses which will probably have
major systemic effects (Li et al., 2012)), which means it cannot
be used in conjunction with the numerous gene knockout mod-
els available in that species. Much of the interest in EDS has cen-
tred on the key observation that the Leydig cell population in the
adult will regenerate in 3–6 weeks following ablation (Kerr et al.,
1985; Molenaar et al., 1986). This is important because it shows
that Leydig cell stem cells persist in the adult testis and that the
potential exists to regenerate Leydig cells in situations such as
ageing where Leydig number and/or activity is reduced (Chen
et al., 1996). In addition, Leydig cell re-generation after EDS
appears to closely resemble normal development of the adult
Leydig cell population thereby providing a model system for
study of this process (Teerds & Rijntjes, 2007; Guo et al., 2013).
The advantages of this model over normal development are that
the interstitium is clear of Leydig cells and so there can be no
confusion between developing and mature Leydig cells, other
developmental events in the testis are not occurring simultane-
ously and hormone levels can be more easily manipulated in the
more mature animals.
Study of Leydig cell re-generation after EDS has identified the
origin of the differentiating Leydig cells, the role of gonadotro-
phins and has started to identify other factors which may be
involved in the process. The identity of the adult Leydig cell pre-
cursor population has been contentious for a number of years
with pericytes, peritubular cells, fibroblasts, and endothelial cells
all suggested (Jackson et al., 1986; Kerr et al., 1987; Teerds et al.,
1990; Davidoff et al., 2004; O’Shaughnessy et al., 2008b; Stanley
et al., 2012). Recent data indicates, however, that the major
source of adult Leydig cells after EDS treatment are peritubular
cells (O’Shaughnessy et al., 2008b; Stanley et al., 2012) although
a contribution from other sources cannot be ruled out. The role
of gonadotrophins in Leydig cell regeneration was established in
early EDS studies using hypophysectomised rats or testosterone
implants. This work showed that Leydig cell regeneration after
EDS is dependent on LH (Molenaar et al., 1986; Sriraman et al.,
2003) although some early proliferation and differentiation
appears to occur independent of LH (Teerds et al., 1989). Subse-
quent studies have shown that similar control mechanisms regu-
late normal adult Leydig cell development at puberty (Clark
et al., 2000; Gnessi et al., 2000; Baker & O’Shaughnessy, 2001;
Zhang et al., 2001, 2004; Baker et al., 2003). Other factors such as
DHH, PDGF and anti-Mu¨llerian hormone (AMH) have been
implicated in the development of Leydig cells both during devel-
opment and re-generation (Salva et al., 2004; Josso et al., 2006;
O’Shaughnessy et al., 2008b) and further studies on EDS regen-
eration have also suggested that nerve growth factor (NGF) and
Sertoli cells are involved in Leydig cell proliferation, differentia-
tion and survival (Yan et al., 2000; Zhang et al., 2013).
While progress has clearly been made in our understanding of
adult Leydig cell development and regeneration using EDS,
questions remain to be answered. For example data frommutant
and knockout mice make it clear that LH is essential for Leydig
cell differentiation but do changes in LH concentrations explain
the onset and control of Leydig cell development? LH levels cer-
tainly rise after EDS treatment (Molenaar et al., 1986) and treat-
ment of normal adult rats with LH or hCG for up to 5 weeks is
reported to stimulate an increase in Leydig cell number (Chris-
tensen & Peacock, 1980; Teerds et al., 1988; Mendis-Handagama
et al., 1998). Ablation of the germ cell population at the same
time as EDS treatment, however, has been shown to cause more
rapid regeneration of the Leydig cells without further affecting
LH levels (Molenaar et al., 1986; Risbridger et al., 1987). It is also
not clear that circulating LH levels rise prior to the start of nor-
mal adult Leydig cell development (Selmanoff et al., 1977;
Michael et al., 1980; Jean-Faucher et al., 1983; Murphy et al.,
1994). Finally, we have shown that Sertoli cell ablation prevents
normal Leydig cell development (Rebourcet et al., 2014b) (see
also section 6) indicating that the Sertoli cells must be involved
in this process. As suggested above, understanding what regu-
lates Leydig cell development might allow controlled regenera-
tion of Leydig cells in circumstances where Leydig cell numbers
and/or activity are reduced. This may be particularly relevant to
ageing (Beattie et al., 2015) as Leydig cells which regenerate in
aged rats after EDS treatment have similar activity to Leydig cells
from young rats and they are able to maintain serum testos-
terone levels in the aged rats at the same level as those in young
rats (Chen et al., 1996).
Leydig cell ablation by EDS causes a marked reduction in
intra-testicular androgen levels and this technique has been
used to investigate the role of androgens in the testis, particu-
larly with reference to Sertoli cell function and spermatogenesis.
Other techniques such as hypophysectomy or treatment with
GnRH agonists or androgen receptor antagonists will have simi-
lar effects, however, and so data coming from EDS experiments
are not unique in that respect. One of the more interesting
observations using EDS was made in 1988 and showed that sper-
matogenesis can largely be maintained after EDS if the animal is
treated with sufficient androgen (Sharpe et al., 1988). This
implies that androgen is the only Leydig cell product that is
essential for spermatogenesis although a repeat of this study
with more up-to-date and sensitive measures of spermatogene-
sis and Sertoli cell activity would appear to be warranted.
The ability to ablate a specific cell type in a tissue should allow
the identification of transcripts or proteins, which are specific to
that cell type, or that rely on that cell type. This technique has
been used, for example to show that expression and activity of
the steroidogenic enzymes, with the exception of HSD17B3, is
limited to the Leydig cells (Murphy & O’Shaughnessy, 1992;
O’Shaughnessy et al., 2008b). More recently, arrays have been
used in two independent studies to identify a comprehensive set
of Leydig cell-specific transcripts in the EDS rat model
(O’Shaughnessy et al., 2014; Zhang et al., 2015). In both studies
transcripts were identified that showed markedly reduced
expression following Leydig cell ablation and in each case this
included most of the known Leydig cell-specific transcripts. Per-
haps surprisingly, however, there are quite marked differences in
the lists of Leydig cell transcripts identified in the two studies.
For example of the 67 known genes identified by Zhang and col-
leagues (Zhang et al., 2015) as Leydig cell exclusive only 23 are
also identified by O’Shaughnessy and colleagues
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(O’Shaughnessy et al., 2014). There are technical differences
between the studies (e.g. the arrays used are different) but, per-
haps more pertinent, the models are also slightly different.
Zhang and colleagues (Zhang et al., 2015) used a ‘standard’ EDS
model (normal adult rats treated once with EDS), whereas
O’Shaughnessy and colleagues (O’Shaughnessy et al., 2014) used
a germ cell-free rat model. The rational for using germ cell-free
animals being that the reduction in androgen levels caused by
EDS ablation of Leydig cells will cause germ cell apoptosis (Kerr
et al., 1993) and, therefore, significant loss of germ cell-specific
transcripts. This is turn may complicate identification of tran-
scripts lost through direct ablation of the Leydig cells. Despite
differences between studies, however, the approach to identify-
ing cell-specific transcripts through cell ablation holds signifi-
cant promise, and further studies should resolve differences in
results so far published.
MACROPHAGES
The resident testicular macrophages (characterised as CD68,
CD163+; ‘ED2’) form the largest population of immune cells in
the testis, and form a close physical and physiological relation-
ship with Leydig cells in the testicular interstitium [reviewed in
(Winnall & Hedger, 2013)], with approximately one resident
macrophage for every four Leydig cells (Bergh, 1985). Under
non-inflammatory conditions, this population undergoes natu-
ral turnover through a slow infiltration of circulating (CD68+,
CD163 ‘ED1’) monocytes/macrophages followed by a local
conversion into the ED2 resident form (Sauter et al., 2014).
Macrophage ablation has significantly enhanced our under-
standing of cell–cell communication in the testis (Fig. 4). In a
series of elegant studies in the rat, the testicular function of the
resident macrophage population has been investigated using
injection of liposome-entrapped dichloromethylene diphospho-
nate into the testicular interstitium to ablate the macrophages
(Bergh et al., 1993a). This treatment regimen in the adult
reduces macrophage number in the injected testis by 90% 7 days
post injection (Fig. 2). Results from these studies show that
macrophages may play a previously unknown role in support of
Leydig cell development and function as well as secreting factors
that inhibit hCG-induced testicular inflammation (Bergh et al.,
1993b). During pre-pubertal development, macrophage ablation
results in an arrest in the size of the Leydig cell population until
day 35, when macrophage repopulation permits ongoing Leydig
cell development. Furthermore, the authors have demonstrated
that, whereas exogenous hCG treatment for 6 days from day 21
results in a seven-fold increase in numbers of Leydig cells, no
increase in Leydig cell number is observed in the contralateral,
macrophage-ablated testis (Gaytan et al., 1994a), an observation
confirmed in hypophysectomised and macrophage-depleted
rats treated with hCG (Gaytan et al., 1995c). Importantly, in this
study, treatment with FSH increased testicular weight and semi-
niferous tubule diameter independently of macrophage ablation,
demonstrating that macrophages are dispensable for this aspect
of testis function (Gaytan et al., 1995c). This first indication of
an essential role for testicular macrophages in the development
of the Leydig cell population has been examined further using
the EDS model of induced Leydig cell ablation and regeneration,
with or without concurrent macrophage ablation. Results from
this study showed that macrophages are essential for regenera-
tion of the Leydig cell population after EDS, with the size of the
population proportional to the number of macrophages, hinting
at a physical, numerical and physiological relationship between
the two populations (Gaytan et al., 1994b,c). In a contrasting
study, the role of macrophages in removal of apoptotic cells has
also been investigated. When Leydig cell ablation was carried
out 10 days after macrophage ablation there was a resultant
influx of inflammatory lymphocytes and monocytes, not seen in
the contralateral macrophage-containing testis. This suggests
that resident macrophages may act to prevent a systemic inflam-
matory response to localised cell death in the testis (Gaytan
et al., 1995b).
Unilateral macrophage ablation in the adult testis results in
increased LH, circulating testosterone and intra-testicular
testosterone concentrations, with intra-testicular testosterone
concentrations higher in the macrophage-retaining testis. This
suggests that, although macrophages are essential for the devel-
opment of the Leydig cell population, once established the
macrophages enhance Leydig cell steroidogenesis, but are not
essential (Gaytan et al., 1996). Indeed, treatment with hCG fol-
lowing bilateral ablation of the macrophage population leads to
a 3.5-fold increase in serum testosterone, compared with an 8.6-
fold increase in intact controls (Gaytan et al., 1995a). A number
of studies have also focussed on deciphering the mechanism
involved in macrophage regulation of Leydig cell function. Using
macrophage-conditioned media a lipophilic factor has been
identified (Hutson et al., 1996) which appears to alter Leydig cell
androgen synthesis through a StAR-independent pathway
(Lukyanenko et al., 1998).
An alternative method of ablating the macrophage population
in adulthood, – chronic 6-week treatment with anti-CSF1R anti-
body (which prevents development of replacement macro-
phages) – causes a small but significant reduction in testis
weight (Sauter et al., 2014). In this study, however, circulating
LH and testosterone were unaffected, perhaps reflecting the
development of a compensatory mechanism over the time
course of treatment in contrast to the rapid induction of macro-
phage death caused by liposome injection. Alternatively, these
data would support the suggestion that the mechanism by which
macrophages are removed is responsible for the negative
impacts on testicular function (Sauter et al., 2014) and highlights
the need for further study in this area.
In summary, these ablation studies suggest that macrophages
play an essential role in the development of the adult Leydig cell
population and are also important for support of steroidogenesis
in adulthood (Hutson, 1998), but have little direct impact on the
seminiferous tubule.
SERTOLI CELLS
Sertoli cell differentiation following SRY/SOX9 cascade activa-
tion is the first step of testis development. The important role
that these cells play in orchestrating testicular differentiation
(promotion of foetal Leydig cell and peritubular myoid cell
development) and subsequent masculinisation of the foetus is
well established (Svingen & Koopman, 2013). During foetal and
early postnatal life there is a period of intensive Sertoli cell pro-
liferation which ceases at puberty as the cells undergo a funda-
mental change in activity (Sharpe et al., 2003) (O’Shaughnessy,
2015). Inter-Sertoli cell junctional complexes form to generate
the BTB, which creates a stable microenvironment for germ cell
development/maturation. In adulthood, Sertoli cells act to
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maintain spermatogenesis with each Sertoli cell able to support
a fixed number of germ cells such that the numbers of spermato-
zoa produced is dependent upon total Sertoli cell number
(Berndtson & Thompson, 1990). Overall, Sertoli cells are essen-
tial for testis differentiation but whether they remain the central
drivers of testis development beyond this point or, indeed,
whether they play a major role in adult testis function, beyond
spermatogenesis, has remained unknown for many years.
Clearly the answer to these questions could be provided by cell
ablation studies although this has proven difficult with respect
to Sertoli cells until recent technological developments. These
recent studies have uncovered many previously unknown roles
for Sertoli cells in testis development and function (Fig. 4).
It has been shown that Sertoli cells will undergo apoptosis
postnatally in mice lacking Sertoli cell expression of Dicer, which
is required for micro RNA and small interfering RNA biogenesis
(Papaioannou et al., 2009; Kim et al., 2010). Sertoli cell apoptosis
starts at about postnatal day 3 in these animals although some
Sertoli cells survive into adulthood. There is massive germ cell
apoptosis in these animals and by 6 months of age the architec-
ture of the testis has degenerated with only rare tubules remain-
ing among an apparent abundance of interstitial tissue
(Papaioannou et al., 2009). This model is interesting in so far as
the role of Dicer in the Sertoli cells is concerned but it does not
meet all the criteria for a good experimental model of Sertoli cell
ablation –that is it cannot be precisely controlled and it does not
act quickly. Nevertheless, some of the testicular changes seen in
these animals (tubule degeneration, germ cell loss) mirrors/con-
firms changes seen with a targeted approach to Sertoli cells abla-
tion described below.
An alternative approach to Sertoli cell ablation has been to use
cadmium, a heavy metal which will deplete the seminiferous
tubules of their contents and, potentially, ablate the Sertoli cells
(Shinohara et al., 2003) (Fig. 2). This also does not meet all the
criteria of the ideal cell ablation method as the impact of cad-
mium is not restricted to one testicular cell type (Marettova
et al., 2015) but the Sertoli cells appear to be the most vulnerable
to cadmium exposure and even low doses have specific effects
on the Sertoli cells (vacuolisation, cell contraction, detachment,
inhibition of protein synthesis, apoptosis) (Clough et al., 1990;
Zhang et al., 2010). Given its effect on the Sertoli cells, cadmium
has been used to explore the role of the Sertoli cells in develop-
ment of the spermatogonial stem cell niche. Transplantation of
Sertoli cells into cadmium- and busulfan-treated (Sertoli and
germ cell depleted) seminiferous tubules (Shinohara et al., 2003)
has permitted assessment of the potential of transplanted Sertoli
cells to reconstitute a niche for spermatogonial stem cells and
support active spermatogenesis. Using donor ROSA26-l29 males,
it was possible to evaluate the colonization ability of immature
and adult Sertoli cells and results showed that immature divid-
ing Sertoli cells are more able to effectively colonize the denuded
seminiferous tubules and support recovery of spermatogenesis
in recipient testes (Shinohara et al., 2003).
The recent development of new transgenic mouse models
expressing cytotoxic genes or specific toxin receptors has
opened the door to more refined methods of Sertoli cell ablation
(Palmiter et al., 1987; Saito et al., 2001; Buch et al., 2005). Shino-
mura and colleagues (Shinomura et al., 2014) and our group
(Rebourcet et al., 2014b) have independently applied similar
approaches to drive the expression of diphtheria toxin A
specifically in Sertoli cells from foetal life onwards, inducing Ser-
toli cell ablation from embryonic day 15. In addition, we have
also combined an Amh-Cre line (Lecureuil et al., 2002) and a
iDTR line (Buch et al., 2005) to permit ablation of Sertoli cells
via injection of DTX (Rebourcet et al., 2014a,b) (Fig. 2). The ben-
efit of this inducible ablation model is that Sertoli cells can be
ablated at different time points to assess temporal-specific roles
of this population not only in supporting testis development but
also in adult function (Rebourcet et al., 2014a). These studies
have emphasised the fundamental importance of Sertoli cells,
revealing many previously undocumented roles that the cells
play in the control of testis development and function (Re-
bourcet et al., 2014a,b; Shinomura et al., 2014).
As might be expected given the intricate relationship between
Sertoli cells and germ cells, Sertoli cell ablation studies show that
Sertoli cells are essential for germ cell survival, and that this is
the case both in perinatal and in adult life. Injection of DTX
leads to Sertoli cell death in the adult within 1 day and germ cell
death follows rapidly, with no evidence of germ cells within the
testis 10 days post DTX injection, including complete loss of
mitotic spermatogonia (Rebourcet et al., 2014a; Shinomura
et al., 2014). Only the reintroduction of immature Sertoli cells
allows partial rescue of germ cell degeneration (Shinomura
et al., 2014). These data confirm the crucial role Sertoli cells play
in the development and maintenance of the germ stem cell
niche.
More surprisingly, Sertoli cell ablation in foetal or perinatal life
demonstrates that the tubular architecture is not fully estab-
lished until puberty. Ablation of Sertoli cells either from 15.5 dpc
or in neonatal life induces de-differentiation of peritubular
myoid cells, which no longer express smooth muscle markers.
Recruitment of cells and re-establishment of a myoid signature
can be achieved if single cell testis aggregates are recombined in
xenografts (Rebourcet et al., 2014b), demonstrating that Sertoli
cells actively enforce a myoid fate on peritubular cells through-
out foetal and pre-pubertal development. In contrast, ablation of
Sertoli cells during puberty (day 18) or in adulthood does not
alter the tubular architecture suggesting that peritubular myoid
cells fate is independent from Sertoli cells at this time, or that
the joint deposition of the basement membrane by Sertoli and
peritubular myoid cells is sufficient to stabilise the tubules and
maintain myoid cell differentiation (Rebourcet et al., 2014b).
Our work has also revealed that Sertoli cells regulate the devel-
opment of the adult Leydig cell population and are required for
Leydig cell survival in adulthood. When Sertoli cells are ablated
at postnatal day 2 or day 18 Leydig cell number in adulthood sig-
nificantly decreases (70–90%), probably because of a reduction
in the number of adult Leydig stem cells in the peritubular
region. Perhaps more surprisingly, ablation of Sertoli cells in
adulthood leads to a 75% decrease in LC number with the
remaining cells concentrated in the sub-capsular region and
around the rete testis/tubuli recti. The nature of the factor or
factors linking the Sertoli cells to Leydig cell development and
survival remain uncertain but are of particular interest as they
have the potential to regulate the size and activity of the adult
Leydig cell population.
Finally, ablation of Sertoli cells illustrates the key role that the
peritubular myoid cells play as a component of the blood–testis
barrier. When the Sertoli cells are ablated in adulthood there is
no barrier to infiltration of biotin into the tubules but only about
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10% of tubules show evidence of immune cell penetration of the
tubules (Rebourcet et al., 2014a). This shows that the peritubular
myoid cells and underlying extracellular matrix form an effective
barrier to macrophage invasion of the tubules. In addition, as
peritubular myoid cells in the intact testis will normally act as a
partial barrier to solute penetration of the tubule (Dym & Faw-
cett, 1970), failure to do this in the absence of Sertoli cells sug-
gests that the function is Sertoli cell-dependent.
CONCLUSION
The development and application of these various models of
cell-specific ablation has significantly advanced our under-
standing of testis development and function. The dissection of
the germ stem cell niche, the assignment of cell-specific gene
function, interactions between germ cells and somatic cells and
the exploitation for transplantation studies have all benefitted
from cell ablation approaches. Cell ablation has also had a sig-
nificant impact on our understanding of Leydig cell develop-
ment through identification of a postnatal stem cell population
and then modelling the regeneration of this population. Explor-
ing the role of the enigmatic macrophages, revealing their sig-
nificant influence over Leydig cells and the interplay between
the two cell types would not be possible without using cell abla-
tion techniques. Finally, and most recently, identifying the pre-
viously unknown roles Sertoli cells play in germ cell support,
peritubular myoid cell development and Leydig cell develop-
ment and lifelong support have opened new avenues of
research which can now be explored using the more conven-
tional tool-kit of the research scientist. With these studies
describing the effects of Sertoli cell ablation, the remaining
major cell type to be pursued in the testis is the peritubular
myoid cell. It may prove difficult to target these cells specifically
because of their similarity to smooth muscle cells but the effort
is likely to be worthwhile as a number of recent studies have
highlighted the importance of the peritubular myoid cells to tes-
tis function (Welsh et al., 2009, 2012; Nurmio et al., 2012; Qian
et al., 2013; Chen et al., 2014). Other studies of interest would
be the development of an inducible Leydig cell ablation model
in the mouse to combine with the available gene knockout
models and another testis macrophage ablation model to com-
plement the earlier liposome studies.
While it is likely that specific gene ablation studies and other
techniques will answer many of the remaining questions in tes-
tis biology, it can be argued that the types of cell ablation stud-
ies described here are essential precursors which lay the
foundation for further advances in the field. Cell ablation as a
technique lacks subtlety, but when used judiciously, it supports
great leaps in understanding not possible via other approaches;
as such it represents an essential component in the researchers’
tool-kit, and should be viewed as a complement to the more
mainstream approaches to advancing our understanding of
testis biology.
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